OCGN Q3 2020 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$710M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$10M

Net Income

-$10M

EPS (Diluted)

$-0.07

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$126,290

Balance Sheet

Total Assets

$21M

Total Liabilities

$6M

Stockholders' Equity

$14M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$10M	-$3M	-275.2%
Net Income	-$10M	-$23M	+54.0%